Detalhe da pesquisa
1.
Contribution of LTi and TH17 cells to B cell aggregate formation in the central nervous system in a mouse model of multiple sclerosis.
J Neuroinflammation
; 16(1): 111, 2019 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31138214
2.
Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis.
J Neuroinflammation
; 15(1): 225, 2018 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30098594
3.
Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis.
J Neuroinflammation
; 14(1): 148, 2017 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28738885
4.
Identification of a B cell-dependent subpopulation of multiple sclerosis by measurements of brain-reactive B cells in the blood.
Clin Immunol
; 152(1-2): 20-4, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24607792
5.
B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 8(3)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33707177
6.
CEACAM1 mediates B cell aggregation in central nervous system autoimmunity.
Sci Rep
; 6: 29847, 2016 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27435215
7.
The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients.
Sci Rep
; 5: 14265, 2015 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26387426
8.
KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis.
Front Neurol
; 5: 62, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24817862